午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

優(yōu)惠券使用說明>

暫無可領(lǐng)優(yōu)惠券

普健生物(武漢)科技有限公司

主營產(chǎn)品:高活性重組蛋白,功能性抗體試劑,試劑盒,技術(shù)服務(wù),項目定制

客服熱線:027-87008169 17762441161

產(chǎn)品目錄更多
  • 電話:027-87008169 17762441161
  • 郵箱:qcheng@atagenix.com
  • 網(wǎng)址:http://www.atagenix.com/
  • 國籍:中國
  • 地址:武漢市東湖新技術(shù)開發(fā)區(qū)神墩四路666號C棟1層,2層
  • 企業(yè)認(rèn)證:
  • 企業(yè)體檢:
  • CB指數(shù):58

武漢艾必賽生物有限公司推薦Anti-FMDV Capsid protein VP1 Antibody (4A2),精品抗體

發(fā)布日期:2025/6/30 17:17:39發(fā)布人:普健生物(武漢)科技有限公司

鏈接:https://www.abinscience.cn/product/34/15139.html

名稱:Anti-FMDV Capsid protein VP1 Antibody (4A2)

貨號:VK500033

適用物種:Foot-and-mouth disease virus (isolate Bovine/Brazil/A24Cruzeiro/1955serotype A) (FMDV)

寄主物種:Human

形式:Liquid

純度:>95% as determined by SDS-PAGE.

克隆性:Monoclonal

同種型:IgG1, kappa

應(yīng)用:ELISA, WB

UniProtP03309

靶點:Genome polyprotein, Leader protease, Lpro, 3.4.22.46, Capsid protein VP1, P1D, Virion protein 1

用途范圍:僅用于科研

儲存:Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

 

產(chǎn)品介紹:Anti-FMDV Capsid protein VP1 Antibody (4A2) 是一種單克隆抗體,靶向口蹄疫病毒(FMDV)衣殼蛋白 VP1。口蹄疫病毒是一種高度傳染性的病毒,可感染偶蹄動物,如牛、豬和羊等,對畜牧業(yè)造成嚴(yán)重威脅。VP1 是該病毒衣殼的主要結(jié)構(gòu)蛋白之一,對病毒的感染性和免疫原性具有重要作用。該抗體可用于檢測樣本中的 FMDV VP1 蛋白,通過 ELISA Western Blot 等實驗技術(shù),幫助研究人員在口蹄疫病毒的診斷、疫苗研發(fā)以及病毒生物學(xué)研究等方面取得重要進(jìn)展。abinScience產(chǎn)品具有親和力高,靈敏度高,特異性好,穩(wěn)定性強等優(yōu)勢。

 

 

產(chǎn)品購買聯(lián)系方式:027-87433958/17302791434

郵箱:info@abinscience.com

參考文獻(xiàn):

 

Virus-like particles of recombinant PCV2b carrying FMDV-VP1 epitopes induce both anti-PCV and anti-FMDV antibody responses. PMID: 30338355
Construction, Expression and Evaluation of Recombinant VP2 Protein for serotype-independent Detection of FMDV Seropositive Animals in Egypt. PMID: 31300744
Adenovirus-Vectored Capsid Proteins of the Serotype A Foot-and-Mouth Disease Virus Protect Guinea Pigs Against Challenge. PMID: 32733405
Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus. PMID: 8970972
Eight novel single chain antibody fragments recognising VP2 of foot-and-mouth disease virus serotypes A, O, and SAT 2. PMID: 31170612
Modified-live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimer forms of foot-and-mouth disease capsid protein epitopes on surface of hybrid virus particles. PMID: 1718244
Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs. PMID: 28365796
Hepatitis E Virus Capsid as a Carrier of Exogenous Antigens for the Development of Chimeric Virus-Like Particles. PMID: 34695827
Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers. PMID: 31493951
A 12-residue epitope displayed on phage T7 reacts strongly with antibodies against foot-and-mouth disease virus. PMID: 29564523
A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles. PMID: 27294397
Application of a recombinant capsid polyprotein (P1) expressed in a prokaryotic system to detect antibodies against foot-and-mouth disease virus serotype O. PMID: 25701759
Potent neutralization activity against type O foot-and-mouth disease virus elicited by a conserved type O neutralizing epitope displayed on bovine parvovirus virus-like particles. PMID: 30547855
Immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus O/China99. PMID: 15837227
Novel 6xHis tagged foot-and-mouth disease virus vaccine bound to nanolipoprotein adjuvant via metal ions provides antigenic distinction and effective protective immunity. PMID: 27209448
Generation and characterisation of recombinant FMDV antibodies: Applications for advancing diagnostic and laboratory assays. PMID: 30114227
Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-and-mouth disease epitopes. PMID: 1722936
The immune response to a recombinant Lactococcus lactis oral vaccine against foot-and-mouth disease virus in mice. PMID: 32385744
Induction of protective immunity in swine by recombinant bamboo mosaic virus expressing foot-and-mouth disease virus epitopes. PMID: 17900346
Promising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type O in swine. PMID: 21084463
Antigenicity and Immunogenicity Analysis of the E. coli Expressed FMDV Structural Proteins; VP1, VP0, VP3 of the South African Territories Type 2 Virus. PMID: 34072100
Enhanced sensitivity in detection of antiviral antibody responses using biotinylation of foot-and-mouth disease virus (FMDV) capsids. PMID: 28689695
Immune responses generated by Lactobacillus as a carrier in DNA immunization against foot-and-mouth disease virus. PMID: 17028078
Efficient production of foot-and-mouth disease virus empty capsids in insect cells following down regulation of 3C protease activity. PMID: 23174161
VP1 B-C and D-E loops of bovine enterovirus cluster B can effectively display foot-and-mouth disease virus type O-conserved neutralizing epitope. PMID: 24077365

 

 

詳情請咨詢 abinScience 亞洲區(qū)官方子公司 —— 武漢艾必賽生物技術(shù)有限公司

官方網(wǎng)址:【中文】https://www.abinscience.cn

【英文】https://www.abinscience.com



武漢艾必賽生物技術(shù)有限公司成立于 2023 年,是 abinScience 在亞洲地區(qū)設(shè)立的官方全資子公司,全面負(fù)責(zé) abinScience 品牌在亞太市場的科研試劑推廣、銷售及技術(shù)支持工作。

依托嚴(yán)格的產(chǎn)品研發(fā)體系和國際化的質(zhì)量管理標(biāo)準(zhǔn),武漢艾必賽與 AtaGenix、ProteoGenix 等知名品牌保持長期戰(zhàn)略合作,現(xiàn)已構(gòu)建起涵蓋抗體、重組蛋白、工具酶、試劑盒、實驗耗材在內(nèi)的多品類供應(yīng)體系,面向區(qū)域內(nèi)科研機構(gòu)、高校實驗室與生物醫(yī)藥企業(yè),提供穩(wěn)定、高效、可信賴的產(chǎn)品與服務(wù)。

核心業(yè)務(wù)覆蓋:
抗體產(chǎn)品(單抗、多抗、重組抗體等)
蛋白與多肽試劑(標(biāo)簽蛋白、功能蛋白等)
分子與細(xì)胞實驗相關(guān)耗材
定制化研發(fā)服務(wù)(蛋白表達(dá)、抗體定制、親和力成熟等)
科研供應(yīng)鏈整合與項目配套支持

武漢艾必賽始終秉持“Empowering Bioscience Discovery”的理念,為亞太地區(qū)的生命科學(xué)研究持續(xù)注入高質(zhì)量動能。

 


相關(guān)新聞資訊
  • 2025/08/04
    武漢艾必賽生物技術(shù)有限公司成立于2023年,是abinScience在亞洲地區(qū)的官方全資子公司,主要負(fù)責(zé)abinScience品牌在亞太市場的科研試劑推廣、銷售及技術(shù)支持工作。公司依托嚴(yán)格的研發(fā)體系和成熟的國際合作平臺,與ProteoGenix品牌保持穩(wěn)定合作,為區(qū)域內(nèi)科研機構(gòu)和醫(yī)藥企業(yè)提供高質(zhì)量產(chǎn)品及專業(yè)服務(wù)。 渠道優(yōu)勢支持體系 培訓(xùn)支持 定期開展線上及線下培訓(xùn),提
  • 2025/08/01
    新冠病毒(SARS-CoV-2)自2019年末爆發(fā)以來,對全球公共衛(wèi)生造成了巨大的影響,病毒通過刺突蛋白(S蛋白)與宿主細(xì)胞的ACE2(血管緊張素轉(zhuǎn)換酶2)受體結(jié)合實現(xiàn)感染,這一過程涉及復(fù)雜的膜融合機制,從初始的ACE2受體結(jié)合到S1亞單位脫落,最終形成六螺旋束(6-HB)結(jié)構(gòu),促進(jìn)病毒與宿主細(xì)胞膜的融合。然而,S蛋白在ACE2結(jié)合與S1脫落之間的早期融合中間態(tài)(early fusion inte
  • 2025/07/31
    在癌癥免疫治療領(lǐng)域,免疫檢查點抑制劑(ICBs)已革新了多種實體瘤的治療方式。然而卵巢癌,尤其是卵巢透明細(xì)胞癌(OCCC),對ICBs的反應(yīng)率較低,通常僅為515%。目前常用的生物標(biāo)志物如PD-L1表達(dá)、腫瘤突變負(fù)荷(TMB)、BRCA1/2突變以及同源重組缺陷(HRD)在OCCC中并未表現(xiàn)出顯著的預(yù)測價值。但一項近期發(fā)表于Nature的研究顯示,PPP2R1A基因的突變可能會極大改變這些患者的預(yù)

查看更多

商家暫時不對外公布

主頁 | 企業(yè)會員服務(wù) | 廣告業(yè)務(wù) | 聯(lián)系我們 | 舊版入口 | 中文MSDS | CAS Index | 常用化學(xué)品CAS列表 | 化工產(chǎn)品目錄 | 新產(chǎn)品列表 | 評選活動| HS海關(guān)編碼
Copyright © 2008 ChemicalBook 京ICP備07040585號  京公網(wǎng)安備 11010802032676號  All rights reserved.
熱線電話:400-158-6606